Compliance with surgical care improvement project measures and hospital-associated infections following hip arthroplasty

Journal of Bone and Joint Surgery

Volumn 94, Issue 15, 2012, Pages 1359-1366

  Wang, Zhong ^a   Chen, Foster ^a   Ward, Michael ^a   Bhattacharyya, Timothy ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIP ARTHROPLASTY; HOSPITAL INFECTION; HUMAN; ICD-9-CM; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL CARE IMPROVEMENT PROJECT; VENOUS THROMBOEMBOLISM;

EID: 84865079177     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.K.00911     Document Type: Article

References (27)

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5.
2. Urquhart DM, Hanna FS, Brennan SL,Wluka AE, Leder K, Cameron PA, Graves SE, Cicuttini FM. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty. 2010 Dec;25(8):1216-22.e1-3. Epub 2009 Oct 30.
3. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008 Oct;23(7):984-91. Epub 2008 Apr 10.
4. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009 Jan;91(1): 128-33.
5. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):338S-400S.
6. Deep vein thrombosis/pulmonary embolism federal registrar. 2008;73(161):48480- 48482. http://edocket.access.gpo.gov/2008/pdf/E8-17914.pdf. Accessed 2011 Jan 11.
7. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006 Aug 1;43(3):322-30. Epub 2006 Jun 16.
8. Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA. 2010 Jun 23;303(24):2479-85.
9. Hawn MT, Itani KM, Gray SH, Vick CC, Henderson W, Houston TK. Association of timely administration of prophylactic antibiotics for major surgical procedures and surgical site infection. J Am Coll Surg. 2008 May;206(5):814-9; discussion 819-21. Epub 2008 Mar 4.
10. Ingraham AM, Cohen ME, Bilimoria KY, Dimick JB, Richards KE, Raval MV, Fleisher LA, Hall BL, Ko CY. Association of surgical care improvement project infection-related process measure compliance with risk-adjusted outcomes: implications for quality measurement. J Am Coll Surg. 2010 Dec;211(6):705-14.
11. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH. A metaanalysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38.
12. Asensio A, Ramos A, Múñez E, Vilanova JL, Torrijos P, García FJ. Preoperative low molecular weight heparin as venous thromboembolism prophylaxis in patients at risk for prosthetic infection after knee arthroplasty. Infect Control Hosp Epidemiol. 2005 Dec;26(12):903-9.
13. Minnema B, Vearncombe M, Augustin A, Gollish J, Simor AE. Risk factors for surgical-site infection following primary total knee arthroplasty. Infect Control Hosp Epidemiol. 2004 Jun;25(6):477-80.
14. Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does "excessive" anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007 Sep;22(6 Suppl 2):24-8. Epub 2007 Jul 26.
15. Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007 Jan;89(1):33-8.
16. Burnett RS, Clohisy JC, Wright RW, McDonald DJ, Shively RA, Givens SA, Barrack RL. Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty. 2007 Apr;22(3):317-24.
17. Streiff MB, Haut ER. The CMS ruling on venous thromboembolism after total knee or hip arthroplasty: weighing risks and benefits. JAMA. 2009 Mar 11;301(10):1063-5.
18. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):381S-453S.
19. Haas SB, Barrack RL, Westrich G, Lachiewicz PF. Venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2008 Dec; 90(12):2764-80.
20. New York State Department of Health. Hospital-acquired infections - 2008. 2009. http://www.health.ny.gov/statistics/facilities/hospital/hospital- acquired-infections/2008/docs/hospital-acquired-infection.pdf. Accessed 2011 Jan 11.
21. State inpatient databases of healthcare cost and utilization project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/ sidoverview.jsp. Accessed 2011 Jan 11.
22. New York State Department of Health. Hospital-acquired infection reporting system - 2007. 2008. http://www.health.ny.gov/statistics/facilities/ hospital/hospital-acquired-infections/2007/docs/hospital-acquired-infection- full-report. pdf. Accessed 2011 Jan 11.
23. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assn. 1979 Dec;74(368):829-836.
24. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998 Jan;36(1):8-27.
25. Tasker A, Harbord R, Bannister GC.Meta-analysis of lowmolecular weight heparin versus placebo in patients undergoing total hip replacement and post-operative morbidity and mortality since their introduction. Hip Int. 2010 Jan-Mar;20(1):64-74.
26. Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, et al. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: A double-blind, randomized comparison. Arch Intern Med. 2000 July 24;160(14):2199-207.
27. Strebel N, Prins M, Agnelli G, Büller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med. 2002 Jul 8;162(13):1451-6.